# CVS HEALTH CORPORATION (CVS) FY2025 Q2 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2025-06-30
- Filing: Q2 FY2025 10-Q, filed 2025-07-31, accession number 0000064803-25-000024
- Page: https://plicit.ai/financials/cvs/fy2025-q2-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2025-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 258,343,000,000 US dollars
- **Current assets**: 75,649,000,000 US dollars
- **Non-current assets**: 182,694,000,000 US dollars
- **Liabilities**: 180,792,000,000 US dollars
- **Current liabilities**: 94,162,000,000 US dollars
- **Non-current liabilities**: 86,630,000,000 US dollars
- **Equity**: 77,551,000,000 US dollars
- **Noncontrolling interest**: 172,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 40,651,000,000 US dollars
- **Inventories**: 17,447,000,000 US dollars
- **Cash and cash equivalents**: 11,787,000,000 US dollars
- **Other current assets**: 3,378,000,000 US dollars
- **Investments**: 2,386,000,000 US dollars
- **Goodwill**: 91,203,000,000 US dollars
- **Long-term investments**: 29,858,000,000 US dollars
- **Intangible assets, net**: 26,224,000,000 US dollars
- **Operating lease right-of-use assets**: 15,512,000,000 US dollars
- **Property and equipment, net**: 12,825,000,000 US dollars
- **Other assets**: 5,214,000,000 US dollars
- **Separate accounts assets**: 1,858,000,000 US dollars
- **Pharmacy claims and discounts payable**: 26,338,000,000 US dollars
- **Accrued expenses and other current liabilities**: 23,101,000,000 US dollars
- **Accounts payable**: 17,258,000,000 US dollars
- **Health care costs payable**: 15,271,000,000 US dollars
- **Current portion of long-term debt**: 6,160,000,000 US dollars
- **Short-term debt**: 3,040,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,906,000,000 US dollars
- **Other insurance liabilities**: 1,088,000,000 US dollars
- **Long-term debt**: 57,290,000,000 US dollars
- **Long-term operating lease liabilities**: 14,328,000,000 US dollars
- **Other long-term liabilities**: 4,782,000,000 US dollars
- **Other long-term insurance liabilities**: 4,769,000,000 US dollars
- **Deferred income taxes**: 3,603,000,000 US dollars
- **Separate accounts liabilities**: 1,858,000,000 US dollars
- **Retained earnings**: 63,936,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,785 shares issued and 1,267 shares outstanding at June 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus**: 50,020,000,000 US dollars
- **Accumulated other comprehensive income (loss)**: 272,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 172,000,000 US dollars
- **Treasury stock, at cost: 518 shares at June 30, 2025 and December 31, 2024**: negative 36,849,000,000 US dollars
- **Gross equity (calculated)**: 114,400,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.